Aptose Biosciences Inc股票

Aptose Biosciences, Inc. (APTO) Stock Price, Quote ... Find the latest Aptose Biosciences, Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing. Aptose Biosciences Inc(APTO)股票价格_行情_走势图—东方财富网提供Aptose Biosciences Inc(APTO)股票的行情走势、五档盘口、逐笔交易等实时行情数据，及Aptose Biosciences Inc(APTO)的资讯、公司公告、研究报告、行业研报、F10资料、行业资讯、资金流分析、阶段涨幅、所属板块、财务指标、机构观点、行业排名、估值水平、股吧互动等与Aptose Biosciences Inc(APTO)有关的信息和

Aptose Biosciences Inc(usapto)股吧，股民朋友可以在这里畅所欲言，分析讨论股票名的最新动态。东方财富股吧，专业的股票论坛社区。

查看即時aptose biosciences inc圖表以追踪其股票的價格行為。查找市場預測，apto財務和市場新聞。 APTO - Aptose Biosciences Inc. - 相關新聞 | 美股 | Anue鉅亨鉅亨美股頻道提供你最完整的APTO - Aptose Biosciences Inc.、美股公司資料、美股股票代號、美股新聞、股價走勢、技術線圖、財報分析、外資分析師評等、歷史股價、盈餘獲利、重要事件及股利配發。临床阶段生物制药公司：Aptose Biosciences Inc.(APTO) | 美股之 …

鉅亨美股頻道提供你最完整的APTO - Aptose Biosciences Inc.、美股公司資料、美股股票代號、美股新聞、股價走勢、技術線圖、財報分析、外資分析師評等、歷史股價、盈餘獲利、重要事件及股利配發。

Jun 05, 2020 Aptose Biosciences, Inc. (APTO) 期權鏈 - Yahoo 財經在 Yahoo 財經查看 APTO 的基本期權鏈，以及比較 Aptose Biosciences, Inc. 的期權。 Aptose Biosciences, Inc. (APTO) Interactive Stock Chart ...

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Its clinical programs is APTO-253, which is a Phase 1b clinical trial for the treatment of patients with relapsed/refractory blood cancers, including acute myeloid

APS.TO Interactive Stock Chart | Aptose Biosciences Inc ... At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. APTO Stock Price | Aptose Biosciences Inc. Stock Quote (U ...

CG-806, an oral, first-in-class pan-FLT3/pan-BTK inhibitor, is in a Phase 1 trial in patients with relapsed or refractory B cell malignancies, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL) and non-Hodgkin lymphoma (NHL), who have failed or …

Aptose Biosciences, Inc. Interactive Chart. 1W 1M 3M 6M YTD 1Y 5Y 10Y MAX. Price Vs S&P500. APTO S&P 500 Index News & Analysis: Aptose Biosciences. All Market Moves Earnings. 10-Q: APTOSE BIOSCIENCES INC. - MarketWatch May 05, 2020 Aptose Biosciences Inc. (APTO) CEO William Rice on Q4 2019 ... Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2019 Earnings Conference Call March 10, 2020 05:00 PM ET Company Participants Susan Pietropaolo - SMP Communications Wi